Asia Pacific Botanical & Plant Derivative Drug Market Forecast 2018-2026

Publisher Name :
Date: 12-Feb-2018
No. of pages: 87

Key Findings

The Asia-Pacific botanical and plant derivative drug market is predicted to rise at 9.01% CAGR over the forecast period of 2018-2026. The market is driven by the rising investment of pharmaceutical companies and increased integration of plant-derived drugs in the market.

Market Insights

The market is segmented on the basis of plant-derived drug type, products, and therapeutic applications. These drugs are less toxic in nature as compared to traditional methods. Indian botanical and plant derivative drug market is expected to exhibit the highest growth over the forecast period. A strong demand for Ayurvedic, Unani and Siddha products have contributed considerably to the leading plant-derivative drug manufacturing companies to gain a strong foothold in this region. Also, major steps have been taken towards the adoption of botanical and plant derivative drugs by the governments of other Asia-Pacific countries like Japan, South Korea, China, Australia, etc.

Competitive Insights

Abbott Pharmaceuticals, GlaxoSmithKline, Glenmark Pharmaceuticals Ltd, Piramal Phytocare Ltd. Bayer Healthcare Llc, Pfizer international, Novartis International Ag, Ranbaxy Laboratories Ltd (Acquired By Sun Pharmaceuticals Ltd), Lupin Ltd, etc. are some of the well-known companies in the market.

Asia Pacific Botanical & Plant Derivative Drug Market Forecast 2018-2026

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Indian Botanical And Plant Derivative Drugs Market To Offer Great Opportunities
3.2.2. Glycosides Is A Quickly Rising Market In Terms of Types
3.2.3. Oncology Holds The Largest Market Share In Terms of Therapeutic Application
3.2.4. Demand For Herbal/Traditional Topical Analgesics Product Is Growing Rapidly
4. Market Dynamics
4.1. Drivers
4.1.1. Growing Applications In Diseases
4.1.2. Growing Fda Approvals
4.1.3. Technological Development In The Manufacturing Process
4.1.4. Rising Demand For Traditional Medicines
4.1.5. Growing Focus Towards Natural Source Medicines
4.2. Restraints
4.2.1. Stringent Regulations Regarding The Use And Approval of Botanical Drugs
4.2.2. Limited Adoption of Botanical And Plant Derivative Drugs
4.3. Opportunities
4.3.1. Rising Fda Approvals For Botanical Drugs
4.3.2. Escalating Usage of Botanical Drugs
4.3.3. Increasing Investment In Asia Pacific
4.4. Challenges
4.4.1. Presence of Substitutes For Botanical & Plant Derivative Drug
4.4.2. Toxicity Related Issues And Safety Concerns
5. Market Segmentation
5.1. Market By Types 2018-2026
5.1.1. Terpenes
5.1.2. Steroids
5.1.3. Glycosides
5.1.4. Phenols
5.1.5. Other Types
5.2. Market By Therapeutic Applications 2018-2026
5.2.1. Oncology
5.2.2. Dermatology
5.2.3. Cns Disorders
5.2.4. Hormone Diseases
5.2.5. Other Therapeutic Applications
5.3. Market By Products 2018-2026
5.3.1. Herbal/Traditional Topical Analgesics
5.3.2. Herbal/Traditional Cough, Cold And Allergy (Hay Fever) Remedies
5.3.3. Herbal/Traditional Digestive Remedies
5.3.4. Herbal/Traditional Dermatological
5.3.5. Herbal/Traditional Pediatric Dietary Supplements
5.3.6. Herbal/Traditional Dietary Supplements
5.3.7. Herbal/Traditional Tonics
6. Key Analytics
6.1. Manufacturing Process
6.2. Value Chain Analysis
6.3. Legal, Policy And Regulatory Framework
6.4. Porter's Five Forces Analysis
6.4.1. Threat of New Entrants
6.4.2. Threats of Substitute Product
6.4.3. Bargaining Power of Buyer
6.4.4. Bargaining Power of Supplier
6.4.5. Intensity of Competitive Rivalry
6.5. Key Buying Criteria
7. Geographic Analysis
7.1. Asia-Pacific
7.1.1. China
7.1.2. India
7.1.3. Japan
7.1.4. Australia
7.1.5. South Korea
7.1.6. Rest of Asia-Pacific
8. Competitive Landscape
8.1. Key Strategies
8.1.1. Merger & Acquisition
8.1.2. Partnership & Collaboration
8.1.3. Expansion & Investment
8.2. Market Share Analysis
8.3. Key Companies Analysis
9. Company Profile
9.1. Abbott Laboratories
9.1.1. Overview
9.1.2. Product Portfolio
9.1.3. Strategic Initiatives
9.1.4. Scot Analysis
9.2. Analyticon Discovery Gmbh
9.2.1. Overview
9.2.2. Product Portfolio
9.2.3. Strategic Initiative
9.2.4. Scot Analysis
9.3. Bayer Healthcare Llc
9.3.1. Overview
9.3.2. Product Portfolio
9.3.3. Scot Analysis
9.4. Boehringer Ingelheim
9.4.1. Overview
9.4.2. Product Portfolio
9.4.3. Strategic Initiative
9.4.4. Scot Analysis
9.5. Bionova
9.5.1. Overview
9.5.2. Product Portfolio
9.5.3. Scot Analysis
9.6. Bristol-Myers Squibb
9.6.1. Overview
9.6.2. Strategic Initiative
9.6.3. Scot Analysis
9.7. Cura Pharm
9.7.1. Overview
9.7.2. Product Portfolio
9.7.3. Scot Analysis
9.8. Dr. Willmar Schwabe Gmbh & Co. Kg
9.8.1. Overview
9.8.2. Product Portfolio
9.8.3. Scot Analysis
9.9. Eli Lilly And Company
9.9.1. Overview
9.9.2. Product Portfolio
9.9.3. Scot Analysis
9.10. Glaxosmithkline
9.10.1. Overview
9.10.2. Product Portfolio
9.10.3. Strategic Initiatives
9.10.4. Scot Analysis
9.11. Glenmark Pharmaceuticals Ltd.
9.11.1. Overview
9.11.2. Product Portfolio
9.11.3. Strategic Initiative
9.11.4. Scot Analysis
9.12. Indena Viale Ortles
9.12.1. Overview
9.12.2. Product Portfolio
9.12.3. Strategic Initiative
9.12.4. Scot Analysis
9.13. Lupin Ltd
9.13.1. Overview
9.13.2. Product Portfolio
9.13.3. Strategic Initiative
9.13.4. Scot Analysis
9.14. Medigene
9.14.1. Overview
9.14.2. Product Portfolio
9.14.3. Strategic Initiatives
9.14.4. Scot Analysis
9.15. Novartis International Ag
9.15.1. Overview
9.15.2. Product Portfolio
9.15.3. Strategic Initiatives
9.15.4. Scot Analysis
9.16. Pfizer
9.16.1. Overview
9.16.2. Product Portfolio
9.16.3. Strategic Initiative
9.16.4. Scot Analysis
9.17. Piramal Phytocare Ltd.
9.17.1. Overview
9.17.2. Product Portfolio
9.17.3. Strategic Initiative
9.17.4. Scot Analysis
9.18. Ranbaxy Laboratories Ltd (Acquired By Sun Pharmaceuticals Ltd)
9.18.1. Overview
9.18.2. Production Portfolio
9.18.3. Strategic Initiative-
9.18.4. Scot Analysis
9.19. Sanofi
9.19.1. Overview
9.19.2. Product Portfolio
9.19.3. Strategic Initiative
9.19.4. Scot Analysis
9.20. Tasly Pharmaceuticals Inc.
9.20.1. Overview
9.20.2. Production Portfolio
9.20.3. Scot Analysis


List of Tables

Table 1 Asia Pacific Botanical & Plant Derivative Drug Market, 2018-2026 ($ Million)
Table 2 Asia Pacific Botanical & Plant Derivative Drug Market, By Types 2018-2026 ($ Million)
Table 3 Asia Pacific Botanical And Plant Derivative Drug Market In Terpenes, 2018-2026 ($ Million)
Table 4 Asia Pacific Botanical And Plant Derivative Drug Market In Steroids 2018-2026 ($ Million)
Table 5 Asia Pacific Botanical And Plant Derivative Drug Market In Glycosides, By Geography 2018-2026 ($ Million)
Table 6 Asia Pacific Botanical And Plant Derivative Drug Market In Phenols, 2018-2026 ($ Million)
Table 7 Asia Pacific Botanical And Plant Derivative Drug Market In Other Types 2018-2026 ($ Million)
Table 8 Asia Pacific Botanical & Plant Derivative Drug Market By Therapeutic Applications 2018-2026 ($ Million)
Table 9 Asia Pacific Botanical And Plant Derivative Drug Market In Oncology, 2018-2026 ($ Million)
Table 10 Asia Pacific Botanical And Plant Derivative Drug Market In Dermatology, 2018-2026 ($ Million)
Table 11 Asia Pacific Botanical And Plant Derivative Drug Market In Cns Disorders, 2018-2026 ($ Million)
Table 12 Asia Pacific Botanical And Plant Derivative Drug Market In Hormone Disease, 2018-2026 ($ Million)
Table 13 Asia Pacific Botanical And Plant Derivative Drug Market In Others Therapeutic Applications 2018-2026 ($ Million)
Table 14 Asia Pacific Botanical And Plant Derivative Drug Market, By Product 2018-2026 ($ Million)
Table 15 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Topical Analgesics, 2018-2026 ($ Million)
Table 16 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Cough, Cold And Allergy (Hay Fever) Remedies, 2018-2026 ($ Million)
Table 17 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Digestive Remedies, 2018-2026 ($ Million)
Table 18 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Dermatologicals, 2018-2026 ($ Million)
Table 19 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Paediatric Dietary Supplements, 2018-2026 ($ Million)
Table 20 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Dietary Supplements, 2018-2026 ($ Million)
Table 21 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Tonics, 2018-2026 ($ Million)
Table 22 Asia Pacific Botanical & Plant Derivative Drug Market 2018-2026 ($ Million)

List of Figures

Figure 1 Asia Pacific Botanical And Plant Derivative Drug Market 2018-2026 ($ Million)
Figure 2 India Botanical And Plant Derivative Drug Market 2018-2026 ($ Million)
Figure 3 Asia Pacific Botanical & Plant Derivative Drug Market In Glycosides 2018-2026 ($ Million)
Figure 4 Asia Pacific Botanical And Plant Derivative Drug Market In Terpenes 2018-2026 ($ Million)
Figure 5 Asia Pacific Botanical And Plant Derivative Drug Market In Steroids 2018-2026 ($ Million)
Figure 6 Asia Pacific Botanical And Plant Derivative Drug Market In Glycosides 2018-2026 ($ Million)
Figure 7 Asia Pacific Botanical And Plant Derivative Drug Market In Phenols 2018-2026 ($ Million)
Figure 8 Asia Pacific Botanical And Plant Derivative Drug Market In Other Types 2018-2026 ($ Million)
Figure 9 Asia Pacific Botanical And Plant Derivative Drug Market In Oncology 2018-2026 ($ Million)
Figure 10 Asia Pacific Botanical And Plant Derivative Drug Market In Dermatology 2018-2026 ($ Million)
Figure 11 Asia Pacific Botanical And Plant Derivative Drug Market In Cns Disorders 2018-2026 ($ Million)
Figure 12 Asia Pacific Botanical And Plant Derivative Drug Market In Hormone Disease 2018-2026 ($ Million)
Figure 13 Asia Pacific Botanical And Plant Derivative Drug Market In Others Therapeutic Applications 2018-2026 ($ Million)
Figure 14 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Topical Analgesics 2018-2026 ($ Million)
Figure 15 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Cough, Cold And Allergy (Hay Fever) Remedies 2018-2026 ($ Million)
Figure 16 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Digestive Remedies 2018-2026 ($ Million)
Figure 17 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Dermatologicals 2018-2026 ($ Million)
Figure 18 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Paediatric Dietary Supplements 2018-2026 ($ Million)
Figure 19 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Dietary Supplements 2018-2026 ($ Million)
Figure 20 Asia Pacific Botanical And Plant Derivative Drug Market In Herbal/Traditional Tonics 2018-2026 ($ Million)
Figure 21 Evolution of Botanical And Plant Derivative Drugs
Figure 22 China Botanical & Plant Derivative Drug Market 2018-2026 ($ Million)
Figure 23 India Botanical & Plant Derivative Drug Market 2018-2026 ($ Million)
Figure 24 Japan Botanical & Plant Derivative Drug Market 2018-2026 ($ Million)
Figure 25 Australia Botanical & Plant Derivative Drug Market 2018-2026 ($ Million)
Figure 26 South Korea Botanical & Plant Derivative Drug Market 2018-2026 ($ Million)
Figure 27 Rest of Asia Pacific Botanical & Plant Derivative Drug Market 2018-2026 ($ Million)
Figure 28 Botanical & Plant Derivative Drug Market Share 2016
  • Global High Content Screening Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124
    Report Overview: High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automa......
  • Global Fragment-Based Drug Discovery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Fragment-Based Drug Discovery market: According to our latest research, the global Fragment-Based Drug Discovery market looks promising in the next 5 years. As of 2022, the global Fragment-Based Drug Discovery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global High Throughput Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Throughput Screening market: According to our latest research, the global High Throughput Screening market looks promising in the next 5 years. As of 2022, the global High Throughput Screening market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate......
  • Global High Content Screening Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 111
    Market Overview of Global High Content Screening market: According to our latest research, the global High Content Screening market looks promising in the next 5 years. As of 2022, the global High Content Screening market was estimated at USD 579.78 million, and it's anticipated to reach USD 1216.18 million in 2028, with a CAGR of 13.14% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the ......
  • Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 88
    Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
  • Global High Content Screening Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 110
    High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
  • Global High Throughput Screening Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 115
    High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
  • Global Fragment-based Drug Discovery Market Insights, Forecast to 2029
    Published: 31-May-2023        Price: US 4900 Onwards        Pages: 111
    The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Market Analysis and Insights: Global Fragment-based Drug Discovery Market The global Fragment-based Drug Discovery market is projected to grow from US$ 365.8 million in 2023 to US$ 533.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The US & Cana......
  • High Throughput Screening Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
    Published: 05-May-2023        Price: US 4150 Onwards        Pages: 146
    The study predicts the short term and long term trends that can shape up the future of the High Throughput Screening market including the COVID-19 pandemic implications for High Throughput Screenings industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs